The obtained results suggest that CXCL5 and CXCL16 may play a role in detection of distant metastases and differentiation between TNM stages, as well as combination of CXCL14 and CRP as potential CRC biomarkers. The gene discussed is CRP; the disease is colorectal carcinoma.